Active, not recruitingPhase 2NCT05923866
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
Studying Multiple system atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ono Pharmaceutical Co. Ltd
- Principal Investigator
- Project LeaderOno Pharmaceutical Co. Ltd
- Intervention
- ONO-2808(drug)
- Enrollment
- 92 target
- Eligibility
- 30-80 years · All sexes
- Timeline
- 2023 – 2025
Study locations (30)
- The Parkinson's Movement and Disorder Institute, Fountain Valley, California, United States
- University of Southern California, Los Angeles, California, United States
- David Geffen School of Medicine at UCLA, Los Angeles, California, United States
- Stanford University School of Medicine, Palo Alto, California, United States
- CenExel Rocky Mountain Clinical Research, Englewood, Colorado, United States
- Yale School of Medicine - Yale Church Street Research Unit (CRSU), New Haven, Connecticut, United States
- Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
- Norman Fixel Institute for Neurological Diseases - University of Florida, Gainesville, Florida, United States
- Mayo Clinic in Florida, Jacksonville, Florida, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- University of Michigan School of Medicine, Ann Arbor, Michigan, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05923866 on ClinicalTrials.govOther trials for Multiple system atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07446894MSA-01 in Multiple System AtrophyTokyo University
- RECRUITINGPHASE2NCT07197866An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyTeva Branded Pharmaceutical Products R&D LLC
- ENROLLING BY INVITATIONNCT07081841AB-1005 Long-Term Follow-up StudyAskBio Inc
- RECRUITINGPHASE1, PHASE2NCT06831500Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.Julien Bally
- RECRUITINGEARLY PHASE1NCT06765733The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System AtrophyBeijing Tiantan Hospital
- RECRUITINGPHASE2NCT06868628A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)Tiziana Life Sciences LTD
- RECRUITINGNCT07353463Shanghai Clinical Cohort - Parkinson's Disease (Reserve)Ruijin Hospital
- RECRUITINGEARLY PHASE1NCT06891703[18F]ACI-15916 PET in α-synucleinopathiesAC Immune SA